Crossmark

Serum calprotectin: could it be a biomarker for disease activity and radiological severity in psoriatic arthritis patients under biological therapy?

Published Online: 2026-01-19

Authors

Shaban Mousa El-Nahal, Ayat

M. Saadoun, Mo’men

M. Ibrahim, Amira

Farouk Balbaa, Mostafa

Hassan Essawy, Sally

Abdelmaksoud Abdelmonsef Ahmed, Hebatalla

T. Elsabagh, Doaa

A. Eissa, Samar
License Information

Text and Data Mining valid from 2026-01-19

Version of Record valid from 2026-01-19
More Information

Article History

Received: 3 November 2025

Accepted: 3 January 2026

First Online: 19 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current